MSB 2.17% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-877

  1. 7,906 Posts.
    lightbulb Created with Sketch. 626
    Cannot remember who the poster was ….last year….who was saying that a way to secure cash without a CR was to set up a royalty scheme essentially mortgaged to the intellectual property portfolio
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.